Navigation Links
FDA approves new device to treat women's bleeding disorder

The government has approved a new method to treat women suffering excessive menstrual bleeding, a device that uses radio waves to zap the tissue at fault. Millions of women suffer menorrhagia, benign but troubling menstrual bleeding so excessive they can require more than 20 tampons in a single day. Thousands of women every year get hysterectomies to cure menorrhagia, while other women try hormone treatment.//

The other option is to destroy part of the lining of the uterus, called the endometrium. Gynecologists can scrape off part of the endometrium, much as they do during abortion, or can use one of a handful of outpatient FDA-approved devices that destroy the endometrium by freezing or heating it.

The Food and Drug Administration approved Novacept Inc.'s NovaSure system as an outpatient electronic treatment for women hoping to cure the bleeding without a hysterectomy. NovaSure is the first of those outpatient options that heats the endometrium using radio-frequency energy. The company said it will begin selling the devices to gynecologists in mid-November.


'"/>




Page: 1

Related medicine news :

1. FDA approves surgical gel
2. FDA approves drug for rare liver disease
3. FDA approves first pocket-sized EKG machine
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
6. Madras High Court Disapproves of Comparative Advertisements
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. Alerts for safety of heart device
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA approves new device treat women bleeding disorder

(Date:5/24/2015)... (PRWEB) May 24, 2015 EnviroLeather™ ... launches “InkGard™ Plus” – a classic, rugged leather ... polymer allowing difficult stains, including ink, to be ... different colors suitable for corporate, healthcare, hospitality and ... line with EnviroLeather’s goal of developing products that ...
(Date:5/24/2015)... ProPin is a set of self-animating 3D pin markers ... to pin point locations on a map, to indicate prices or ... users to choose from 30 simplistic presets with geometric design elements ... editors can easily manipulate ProPin presets as a whole. Pixel ... , Using ProPin is easy, simply drag a preset into the ...
(Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
(Date:5/24/2015)... A report out just last ... best option for avoiding cardiovascular disease is exercise and ... the single most powerful predictor of death and survival, ... and family history of premature death -- a finding ... lung fitness. , The Importance of Cardiovascular Screening , ...
(Date:5/23/2015)... On May 13, Nithyananda Yoga Foundation ... yogic power learned through meditation and initiation at Special ... India. , Yogamaatha, a nine-year-old girl from North Carolina, ... professionals attending the 2015 Business Advocacy Summit at Capitol ... , In a demonstration that lasted three hours, ...
Breaking Medicine News(10 mins):Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3
... , Linton Whitaker, M.D., ... Linton Whitaker, M.D., a craniofacial surgeon at The Children,s ... awarded the prestigious Paul Tessier Medal during the annual meeting ... , The Paul Tessier Medal is the highest honor awarded ...
... , , ... Holding Corp. (Nasdaq: ADAT ), a worldwide provider ... announced that it has completed its previously announced "registered direct" ... proceeds of $3.4 million. , At closing, Authentidate issued ...
... , , ... Services,Holdings Limited (NYSE: CCM ) ("CMS" or "the ... centers in China in terms of,revenues and the total number ... public offering of 12,000,000 American Depositary Shares,("ADSs"), each representing three ...
... , , , PITTSBURGH, Dec. 11 UPMC ... offer award-winning brain fitness software from Posit Science®, at no cost, ... brain training program is a new part of the UPMC Health ... , The brain fitness software, known as the Insight(TM) Brain ...
... risk factors and treatment effects are helping clinicians ... most likely to benefit from close monitoring, lifestyle ... in the December 15/22, 2009, Prevention and Outcomes ... American College of Cardiology aim to disentangle ...
... ... President Obama and Congressional Leadership , ... Washington, D.C. (Vocus) December 11, 2009 -- The Community Oncology Alliance ... their practices if critical Medicare reimbursement fixes for treating cancer patients are not made ...
Cached Medicine News:Health News:Children's Hospital Surgeon Receives Prestigious Paul Tessier Medal 2Health News:Authentidate Holding Corp. Completes Capital Raise 2Health News:Authentidate Holding Corp. Completes Capital Raise 3Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 2Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 3Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 2Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 3Health News:New research identifies modifiable risk factors for heart disease 2Health News:New research identifies modifiable risk factors for heart disease 3Health News:New research identifies modifiable risk factors for heart disease 4Health News:New research identifies modifiable risk factors for heart disease 5Health News:New research identifies modifiable risk factors for heart disease 6Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis 2Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis 3Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis 4
(Date:5/22/2015)... 2015   InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" ... ("EPS"), today announced that its CGuard TM Embolic Prevention ... Prof. Piotr Musialek , at the EuroPCR ... . PARADIGM, an investigator-initiated P rospective ... roti D revascularization I n symptomatic and increased-risk ...
(Date:5/22/2015)... May 22, 2015 Today, Rhodes Pharmaceuticals ... system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity ... Summer 2015. The announcement comes ... from the U.S. Food and Drug Administration (FDA). ... formulation of methylphenidate capsule with an onset of ...
(Date:5/22/2015)... May 22, 2015 Richmond ... research unit with a worldwide reputation for excellence ... frequent publications in peer reviewed medical journals. Its ... and regulators in discussions about rules for transparency ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
... is a fully automated, user-friendly system ... labor resources and improve patient care. ... and immunoturbidimetric testing capabilities with a ... assays. It's also a powerful, intuitive ...
... proteins produced with recombinant technology, that have been ... capable of detecting the different types of T.cruzi ... with amino acid sequences repeated in tandem. SAPA ... phase of the infection, it reacts with 93% ...
Inquire...
... Medtronic Subcutaneous Lead System Model ... with the use of the ... Improved SQ design and implant ... fast and easy procedure, and ...
Medicine Products: